Market Overview:
The global pharmaceutical contract laboratory services market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing demand for outsourcing of laboratory services by pharmaceutical and biotechnology companies, rising number of CROs, and growing focus on quality control and regulatory compliance. The global pharmaceutical contract laboratory services market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into raw materials testing, in-process and product release testing, finished pharmaceutical products testing, environmental samples testing, and other tests. In terms of application area; analytical testing accounted for the largest share in 2017 owing to its widespread use across various stages of drug development process followed by method development & validation activities; stability studies are also gaining importance due to increased number regulatory filings globally coupled with stringent timelines associated with them . Other applications such as impurity profiling/characterization (including identification & quantitation), bioanalytical assay development & validation (including immunoassays), formulation development etc.
Product Definition:
Pharmaceutical Contract Laboratory Services (PCLS) is the provision of laboratory services by a third party to a pharmaceutical or biotechnology company. PCLS is important because it allows companies to outsource non-core functions, which frees up resources that can be used for other purposes. Additionally, it can help improve quality and turnaround times.
Raw Materials Testing:
Raw materials testing is a procedure carried out to examine the chemical and physical properties of raw materials used in pharmaceutical manufacturing. It helps in ensuring that the final product meets all quality requirements before it is packaged and sent for market.
The global raw materials testing market was valued at USD 2,37 billion in 2015.
In-Process and Product Release Testing:
In-process and product release testing is a method used to evaluate the stability of drug products during processing and after they are released for use. It also helps to identify any potential problems that may occur in the course of drug usage. These tests are performed on raw materials as well as final product samples, which include both finished dose formulations and bulk drugs.
Application Insights:
The finished pharmaceutical products testing segment dominated the global market in 2017. This can be attributed to a high number of manufacturers and increasing demand for finished drug products such as biopharmaceuticals, biosimilars, monoclonal antibodies, recombinant proteins & enzymes and other specialty drugs. The method development segment is expected to witness lucrative growth over the forecast period owing to an increase in R&D activities by various companies including Pfizer Inc., Merck KGaA, Novo Nordisk A/S and sanofi-aventis ULC.
Stability Testing segment is also anticipated to grow at a significant rate during the forecast period due primarily to regulatory changes that have resulted in an increased focus on stability studies for new drug applications (NDAs). For instance; In March 2018; FDA approved expanded use of stability data from clinical trials along with pharmacokinetic data from nonclinical studies for NDA approval purposes.
Regional Analysis:
Asia Pacific accounted for the largest revenue share in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to increasing R&D activities in this region, growing outsourcing opportunities, and rising healthcare expenditure by governments of emerging economies such as China & India. In addition, factors such as favorable regulatory scenario coupled with less stringent laws pertaining to product approval are anticipated to create ample growth opportunities for contract laboratory services providers in Asia Pacific during the forecast period.
In terms of revenue generation from method development services, North America held a significant market share owing mainly to high demand stemming primarily from U.S.
Growth Factors:
- Increasing demand for contract laboratory services from the biopharmaceutical and medical device industries due to the rise in R&D spending by these industries.
- The increasing use of contract laboratories by small and medium-sized enterprises (SMEs) to outsource non-core activities, thereby freeing up their resources to focus on their core competencies.
- The growing trend of outsourcing clinical trials to contract research organizations (CROs) as pharmaceutical and biotechnology companies seek to reduce costs and improve efficiency. This is expected to drive demand for contract laboratory services in the coming years.
- The increasing number of approvals granted for new drugs and medical devices, which is leading to an increase in R&D activities within the pharmaceutical industry, thereby fueling demand for contract laboratory services. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Contract Laboratory Services Market Research Report
By Type
Raw Materials Testing, In-Process and Product Release Testing, Finished Pharmaceutical Products Testing, Environmental Samples, Other
By Application
Analytical Testing, Method Development, Stability Testing, Other Testing
By Companies
Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Asymchem, Piramal Pharma Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Contract Laboratory Services Market Report Segments:
The global Pharmaceutical Contract Laboratory Services market is segmented on the basis of:
Types
Raw Materials Testing, In-Process and Product Release Testing, Finished Pharmaceutical Products Testing, Environmental Samples, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Analytical Testing, Method Development, Stability Testing, Other Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eurofins
- WuXi AppTec
- Pace Analytical Services
- Catalent
- LabCorp (Covance)
- PPD
- Element (Exova)
- ALS Pharmaceutical
- Intertek Group
- SGS
- Boston Analytical
- DYNALABS
- ADPEN Laboratories
- ARL Bio Pharma
- West Pharmaceutical
- Microbac
- Element (Analytical Lab Group)
- Asymchem
- Piramal Pharma Solutions
Highlights of The Pharmaceutical Contract Laboratory Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Raw Materials Testing
- In-Process and Product Release Testing
- Finished Pharmaceutical Products Testing
- Environmental Samples
- Other
- By Application:
- Analytical Testing
- Method Development
- Stability Testing
- Other Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Contract Laboratory Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical contract laboratory services are a type of laboratory testing that is contracted by pharmaceutical companies to provide specific tests and analysis. These services can be used to help ensure the quality and safety of medications, as well as to monitor their production.
Some of the major players in the pharmaceutical contract laboratory services market are Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Asymchem, Piramal Pharma Solutions.
The pharmaceutical contract laboratory services market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Contract Laboratory Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Contract Laboratory Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Contract Laboratory Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Contract Laboratory Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Contract Laboratory Services Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Contract Laboratory Services Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Contract Laboratory Services Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Contract Laboratory Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
5.2.1 Raw Materials Testing
5.2.2 In-Process and Product Release Testing
5.2.3 Finished Pharmaceutical Products Testing
5.2.4 Environmental Samples
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Contract Laboratory Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
6.2.1 Analytical Testing
6.2.2 Method Development
6.2.3 Stability Testing
6.2.4 Other Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Contract Laboratory Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Contract Laboratory Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Contract Laboratory Services Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Contract Laboratory Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
9.6.1 Raw Materials Testing
9.6.2 In-Process and Product Release Testing
9.6.3 Finished Pharmaceutical Products Testing
9.6.4 Environmental Samples
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
9.10.1 Analytical Testing
9.10.2 Method Development
9.10.3 Stability Testing
9.10.4 Other Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Contract Laboratory Services Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Contract Laboratory Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
10.6.1 Raw Materials Testing
10.6.2 In-Process and Product Release Testing
10.6.3 Finished Pharmaceutical Products Testing
10.6.4 Environmental Samples
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
10.10.1 Analytical Testing
10.10.2 Method Development
10.10.3 Stability Testing
10.10.4 Other Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Contract Laboratory Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Contract Laboratory Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
11.6.1 Raw Materials Testing
11.6.2 In-Process and Product Release Testing
11.6.3 Finished Pharmaceutical Products Testing
11.6.4 Environmental Samples
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
11.10.1 Analytical Testing
11.10.2 Method Development
11.10.3 Stability Testing
11.10.4 Other Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Contract Laboratory Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Contract Laboratory Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
12.6.1 Raw Materials Testing
12.6.2 In-Process and Product Release Testing
12.6.3 Finished Pharmaceutical Products Testing
12.6.4 Environmental Samples
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
12.10.1 Analytical Testing
12.10.2 Method Development
12.10.3 Stability Testing
12.10.4 Other Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Contract Laboratory Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Contract Laboratory Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Contract Laboratory Services Market Size Forecast by Type
13.6.1 Raw Materials Testing
13.6.2 In-Process and Product Release Testing
13.6.3 Finished Pharmaceutical Products Testing
13.6.4 Environmental Samples
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Contract Laboratory Services Market Size Forecast by Applications
13.10.1 Analytical Testing
13.10.2 Method Development
13.10.3 Stability Testing
13.10.4 Other Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Contract Laboratory Services Market: Competitive Dashboard
14.2 Global Pharmaceutical Contract Laboratory Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eurofins
14.3.2 WuXi AppTec
14.3.3 Pace Analytical Services
14.3.4 Catalent
14.3.5 LabCorp (Covance)
14.3.6 PPD
14.3.7 Element (Exova)
14.3.8 ALS Pharmaceutical
14.3.9 Intertek Group
14.3.10 SGS
14.3.11 Boston Analytical
14.3.12 DYNALABS
14.3.13 ADPEN Laboratories
14.3.14 ARL Bio Pharma
14.3.15 West Pharmaceutical
14.3.16 Microbac
14.3.17 Element (Analytical Lab Group)
14.3.18 Asymchem
14.3.19 Piramal Pharma Solutions
